Aidsmap
Share:
The 29th Conference on Retroviruses and Opportunistic Infections (CROI 2022) was held virtually in two parts. The first part, 12-16 February, included the Opening Session, technical workshops, plenary presentations, interactive sessions, oral sessions, and poster presentations. The second part, 22-24 February, included symposia with state-of-the-art talks and responses to audience questions.
Here is selected coverage from the conference: check out the dedicated page of the site with the major highlights.
Further reading:
Related HIV and Co-Infections News
-
[Press release] FDA grants priority review of New Drug Application for Gilead’s once-daily HIV treatment of bictegravir plus lenacapavir
-
[CROI 2026] HIV i-Base: Investigational HIV combinations – daily, weekly, 4- and 6-monthly…
-
[Press release] FDA approves Merck’s once-daily IDVYNSO™ (doravirine/islatravir)
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.